课题基金 / 基金详情

Craniofacial Dysmorphology Associated with Phelan-McDermid Syndrome using Three-Dimensional Morphometrics

Craniofacial Dysmorphology Associated with Phelan-McDermid Syndrome using Three-Dimensional Morphometrics
使用三维形态测量学与 Phelan-McDermid 综合征相关的颅面畸形
批准号:
9433829
负责人:
Kara E Powder
金额:
$8.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-15 至 2020-08-31

项目摘要

项目成果

Kara E Powder的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This research seeks to characterize the craniofacial dysmorphology associated with Phelan-McDermid syndrome (PMS) (OMIM #606232), a genetic disorder that has been diagnosed in over 1500 individuals. The craniofacial dysmorphology associated with PMS has not been well established. The literature reports a variety of characteristics, including bulbous nose, ear anomalies, full lips, epicanthal folds, macrocephaly, dolicocephaly, high arch palate, full cheeks, periorbitial fullness, pointed chin, wide nasal bridge, long pholtrum, malar hypoplasia, microcephaly, deep set eyes, and flat midface. Our study will include a larger patient population that will provide an understanding of how these dysmorphic features vary in frequency and intensity associated with PMS. The research will use geometric morphometric approaches to allow the variation to be more precisely defined and visualized, so that a more specific and universal understanding of “bulbous nose”, for instance, will emerge. This research will provide a more precise and systematic study of the phenotype associated with PMS with a focus on the facial dysmorphology then has been completed before. The project will optimize the synergies available through cross-disciplinary collaborations between clinicians, developmental biologists, and anatomists thus advancing understanding of PMS cranial dysmorphology beyond what would result if these scientists were working in isolation. The research model will capitalize on clinical expertise of PMS, anatomical science to quantify the dysmorphology, and developmental biology to explore developmental models for characterizing PMS. The initial diagnosis of PMS by clinical geneticists is often based on a characteristic pattern of physical features observed in a patient. To provide a quantitative assessment of the craniofacial dysmorphology associated with PMS, geometric morphometric approaches will provide greater insights into the mean morphology associated with the syndrome along with an evaluation of the variation associated with age, sex, and ancestry differences. Dysmorphology can be evaluated using anatomical landmarks placed within a three-dimensional coordinate system and through dense surface models of the craniofacial complex. This study will advance diagnosis and treatment of PMS in the following ways: (1) Precisely characterize craniofacial dysmorphologies associated with PMS; (2) determine the variation associated by PMS in the patient population; (3) quantify the effects of sex and ancestry associated with the dysmorphologies observed in PMS; and (4) define the impact on growth associated with PMS in the craniofacial complex and within craniofacial regions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Species-specific chromatin structure and its environmental interaction in craniofacial skeletal development andvariation using cichlid fishes
  • 批准号:
    10046780
  • 项目类别:
  • 资助金额:
    $44.45万
  • 财政年份:
    2020
  • 负责人:
    Kara E Powder
  • 依托单位:
Origins of Sexual Dimorphism in the Craniofacial Skeleton
  • 批准号:
    10714167
  • 项目类别:
  • 资助金额:
    $23.04万
  • 财政年份:
    2018
  • 负责人:
    Kara E Powder
  • 依托单位:
Role of the novel regulator lbh in neural crest and craniofacial development
Role of the novel regulator lbh in neural crest and craniofacial development
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: